Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Amides synthesized at AstraZeneca useful for cytokine-mediated diseases

March 17, 2000

Collgard receives orphan drug status for scleroderma therapy

March 15, 2000

New inhibitors of NOS, particularly iNOS, in early development at AstraZeneca

March 14, 2000

CE Mark granted for the Prosorba Column as rheumatoid arthritis Rx

March 14, 2000

Suntory's new antiinflammatory agents act as inhibitors of NF-kB

March 13, 2000

Taisho presents new series of cytokine production inhibitors

March 10, 2000

New nondrug treatment approved for rheumatoid arthritis in Canada

March 10, 2000

NIH grant to support Alexion's 5G1.1 in lupus trials

March 10, 2000

Taisho presents new interleukin production inhibitors with nitroaniline structure

March 9, 2000

InKine initiates pharmacokinetic study of tablet formulation of CBP-1011

March 9, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...